Managing Uncertainty via Deterministic Sensitivity Analysis
Simulating the financial impact of introducing a new technology inherently involves uncertainty. As a result, the central outcome should be seen as an indicative reference for decision-makers who must assess whether the implementation of the new technology aligns with its clinical added value. In one of our previous blogs (“How to Deal with Uncertainties“), we […]
AI in Healthcare: Risks and Opportunities
No one involved in healthcare, including the patient, can ignore it any longer. Artificial intelligence (AI) is deeply embedded in modern healthcare and is evolving rapidly. AI has already provided added value in the clinical interpretation of medical imaging, identification of chronic conditions based on algorithms, and much more. In short, thanks to AI, our quality of […]
Quality of Life – be vigilant!
Δ = innovation – SoC In general, in the world of market access of health care products, quality of life (QoL) is expressed in ‘utilities’. The healthier you are, the higher your utility score is. When performing health economic assessments, the difference in utilities for patients (delta utility) between the situation without and the situation […]
How to extrapolate a limited data set?
Each health economic analysis starts with clinical data. The trick is to reliably estimate the expected outcome using a limited dataset. In other words, if your sample (clinical study) does not provide mature data (interim data, small number of patients, large variance in results, …), how can you use this data as reliably as possible? […]
Clinical data, the key to a good market access dossier
The chicken or the egg. It’s a question that keeps many busy. The budget can be synonymous with the chicken and innovations synonymous with the egg (or the other way around, of course …). Anyway, any kind of innovation results in shifts in resources (lower consumption, higher efficacy, fewer side effects). For pharmaceuticals, it is […]
How to measure the value of innovation?
How to measure health benefits? Within healthcare, there is continuous innovation. New technologies are made available and (partly) replace existing resources or care. But how can you measure the financial value of innovation? It is not because a diagnostic device has 10 x sharper imaging that also a ten-fold health gain will be achieved, let […]